A performance improvement project to increase appropriate reporting of weekly paclitaxel infusion related hypersensitivity adverse drug reactions at a major tertiary cancer center.

• In: Hospital Pharmacy - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: HPS-P-005
• By: LAL, Lincy (University of Texas - MD Anderson Cancer Center, Houston, United States of America)
• Co-author(s): Dana, William (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America)
  Gerber, Donna (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America)
  
• Abstract:

  Objectives: This prospective performance improvement project identifies, intervenes, and measures the impact of a clinical safety and effectiveness program to increase and improve the rate of appropriate reporting of weekly paclitaxel infusion related hypersensitivity reactions in an electronic medical record (EMR) system at a major tertiary..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login